Along with our partnership with the Osteosarcoma Collaboration that brings together patients, parents, physicians, advocates and survivors – OS Therapies is proud to have some of the top Osteosarcoma clinicians and physicians on our Scientific Advisory Board. These leaders in research and patient care are on the front-line looking for new ways to defeat an old adversary. Their guidance sets the scientific and clinical direction that will bring new treatments to Osteosarcoma
Peter M. Anderson, MD - Department of Pediatric Hematology, Oncology and Blood & Marrow Transplantation – Cleveland Clinic
Doug S. Hawkins, MD - Professor of Pediatrics, Hematology/Oncology Division - Center for Clinical and Translational Research – Seattle Children’s
Meenakshi Hegde, MD - Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine – Texas Children’s Hospital
Nabil M. Ahmed, MD - Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine – Texas Children’s Hospital
Alejandro Sweet-Cordero, MD - Pediatric Malignancies - Cancer Genetics - Associate Professor of Pediatrics - UCSF
Brenda Weigel, MD – Professor, Division of Pediatric Hematology and Oncology - Masonic Cancer Center – University of Minnesota
Felasfa M. Wodajo, MD - Orthopaedic Surgery - Musculoskeletal Oncology - INOVA Healthcare System
Please let us know if you would be interested in joining our mission to identify and clinically prove new treatments for OsteoSarcoma. We are located in the Washington Metropolitan area near the NIH, FDA, researchers, capital and a thriving bio-science culture. Join us!
